Essemedical is Omixon’s New Distributor

28/08/2020

Omixon welcomes Essemedical s.r.l. as our New Distributor in Italy Omixon is pleased to announce the signature of a Distribution Agreement with Essemedical s.r.l. (Dia4it s.r.l.), based in Vedano al Lambro (MB), Italy. The agreement is effective as of September 1st, 2020. Our cooperation will provide easier access to Omixon’s high-performance,...

Omixon “Rode the Bull” Again – ASHI, 2016

07/10/2016

Following on from the trends set last year, eight excited members of the Omixon Team went on a trip to outride the best in the rodeo of ASHI 2016 in St. Louis, MO. Thanks to One Lambda for including a mechanical bull to literally let the bull-times ride! Although...

Maggi Woronkowicz Joins Expanding US Operations for Omixon

31/08/2016

Omixon is delighted to announce that Maggi Woronkowicz will join Omixon’s expanding US Operations as a new Sales Director, Americas. Maggi will be joining Chief Commercial Officer, Dr. Peter Meintjes and Sales Director, Faisal Mojaddidi. The US operations will additionally be expanded with Omixon’s senior Field Applications Scientist, and...

The Economics of NGS: A Cost Comparison of NGS Implementations with Legacy Technologies

06/06/2016

Authors: Nóra Nagy, Efi Melista, Krisztina Rigó, Peter Meintjes, Tim Hague Abstract: Recent technological advances in sequencing and related library preparation methods, cumulatively called Next Generation Sequencing (NGS) have provided new opportunities that allow the complete characterisation of the HLA genes in haploid fashion and are beginning to make their...